Bering Capital

Investor type

VC

Founded

2020

AUM

$1 200 M

Location

San Francisco, California, United States

Investment Ticket

$10-50 m

Investment Stage

Seed Pre-seed Series A Series B Late Stage (Series C+)

Region of investment

North America
Investor profile last updated: 16 August, 2026

Profile

Bering Capital is a venture capital firm based in San Francisco, California, founded in 2020 by Evgeny Zaytsev and Philip Sawyer. The firm focuses on investing in innovative biotech and medical technology companies. With a team of five professionals, including two partners, Bering Capital is committed to supporting the growth of cutting-edge healthcare solutions.

The firm primarily invests in life sciences, healthtech, and enterprise applications, targeting Series C and Series D rounds. Bering Capital's investments are concentrated in the United States, and the firm manages Bering Capital Fund I with an AUM of $50 million, launched in 2021. The firm is a Registered Investment Adviser (RIA) and actively seeks new investment opportunities.

Notable portfolio companies include Coherus Biosciences - biopharmaceuticals, Atea Pharmaceuticals - antiviral therapeutics, CalciMedica - drug discovery, Dragon Vascular - vascular solutions, and Life Detection Technologies - monitoring equipment.

Industry

Life Sciences Medical Devices Healthcare Services Digital Biotechnology HealthTech MedTech

Bering Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Bering Capital Fund I
Venture Capital (VC)
Biotechnology
Healthcare Services
MedTech
Life Sciences
Pre-seed
Seed
North America
$5-10 m
$50 M
April 2021

Contacts

Name
Title
Email
avatar
Philip Sawyer Managing Partner
Managing Partner
p•••@•••
avatar
Evgeny Zaytsev Venture capital investor
Venture capital investor
e•••@•••
Upgrade to see contacts
avatar
2GTO3onVZsfdp5ty 2GTO3onVZsfdp5ty
2GTO3onVZsfdp5ty
avatar
2GTO3onVZsfdp5ty 2GTO3onVZsfdp5ty
2GTO3onVZsfdp5ty
avatar
2GTO3onVZsfdp5ty 2GTO3onVZsfdp5ty
2GTO3onVZsfdp5ty
Investment-team contacts for Bering Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Bering Capital

Bering Capital is a venture capital firm. It backs companies at Seed, Pre-seed, Series A, Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Bering Capital is located in San Francisco, California, United States.
Bering Capital was founded in 2020.
Bering Capital invests in companies and startups in Life Sciences, Medical Devices, Healthcare Services, Digital, Biotechnology, HealthTech, MedTech.
Bering Capital invests in companies and startups in North America.
Bering Capital invests in companies and startups at Seed, Pre-seed, Series A, Series B, Late Stage (Series C+).
Bering Capital usually invests $10-50 m on average.
Bering Capital has around $1 200m assets under management.
Bering Capital last fund was created/launched in 2021-04-06
Bering Capital can be reached through its website beringcapital.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Bering Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Bering Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.